Evidence map›Paper›PMID 36574602›Full record

ArticleAngewandte Chemie (International ed. in English)2022

Responsive Peptide Nanofibers with Theranostic and Prognostic Capacity.

Bingbing Sun, Xiaoping Guo, Mei Feng, Shoupeng Cao, Haowen Yang, Hanglong Wu, Marleen H M E van Stevendaal, Roy A J F Oerlemans, Jinning Liang, Yiqiang Ouyang and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. A pH-responsive ZnOJournal of biological engineering · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Responsive Peptide Nanofibers with Theranostic and Prognostic Capacity.Angewandte Chemie (International ed. in English) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Bingbing SunBio-Organic Chemistry, Institute of Complex Molecular Systems, Eindhoven University of Technology, Helix, P. O. Box 513, 5600 MB, Eindhoven, The Netherlands.ORCID http://orcid.org/0000-0002-9934-1248
Xiaoping GuoLaboratory Animal Center, Guangxi Medical University, Nanning, Guangxi 530021, China.ORCID http://orcid.org/0000-0002-4076-6233
Mei FengLaboratory Animal Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
Shoupeng CaoBio-Organic Chemistry, Institute of Complex Molecular Systems, Eindhoven University of Technology, Helix, P. O. Box 513, 5600 MB, Eindhoven, The Netherlands.ORCID http://orcid.org/0000-0002-5856-2407
Haowen YangLaboratory of Immunoengineering, Department of Biomedical Engineering, Institute for Complex Molecular Systems, Eindhoven University of Technology, 5600 MB, Eindhoven, The Netherlands.ORCID http://orcid.org/0000-0002-3196-8917
Hanglong WuBio-Organic Chemistry, Institute of Complex Molecular Systems, Eindhoven University of Technology, Helix, P. O. Box 513, 5600 MB, Eindhoven, The Netherlands.ORCID http://orcid.org/0000-0002-8042-9952
Marleen H M E van StevendaalBio-Organic Chemistry, Institute of Complex Molecular Systems, Eindhoven University of Technology, Helix, P. O. Box 513, 5600 MB, Eindhoven, The Netherlands.
Roy A J F OerlemansBio-Organic Chemistry, Institute of Complex Molecular Systems, Eindhoven University of Technology, Helix, P. O. Box 513, 5600 MB, Eindhoven, The Netherlands.ORCID http://orcid.org/0000-0001-8726-1294
Jinning LiangLaboratory Animal Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
Yiqiang OuyangLaboratory Animal Center, Guangxi Medical University, Nanning, Guangxi 530021, China.
Jan C M van HestBio-Organic Chemistry, Institute of Complex Molecular Systems, Eindhoven University of Technology, Helix, P. O. Box 513, 5600 MB, Eindhoven, The Netherlands.ORCID http://orcid.org/0000-0001-7973-2404

Funding

H2020 Marie Skłodowska-Curie Actions Eurotech Postdoc Programme, No 754462Nederlandse Organisatie voor Wetenschappelijk Onderzoek Spinoza award SPI 71-259
6 · The paper itself

Abstract

Photodynamic therapy (PDT) is a highly promising therapeutic modality for cancer treatment. The development of stimuli-responsive photosensitizer nanomaterials overcomes certain limitations in clinical PDT. Herein, we report the rational design of a highly sensitive PEGylated photosensitizer-peptide nanofiber (termed PHHPEG

Indexed as

Long-Term Tumor RetentionNanofibersPeptidesPhotodynamic TherapySelf-Assembly

Identifiers

PMID36574602
PMCPMC9544150

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.